(Spectrum Science) Corning Incorporated (NYSE: GLW) will feature new 3D cell culture technologies alongside proven and trusted workflow solutions to advance spheroids, organoids, tissue models, and other disease modeling and drug discovery applications at the Society for Laboratory Automation and Screening (SLAS) conference, Jan. 25-29, in San Diego, Calif.

Original source: https://www.eurekalert.org/pub_releases/2020-01/ss-cls011020.php